JPH0558911A - 鎮咳去痰剤 - Google Patents

鎮咳去痰剤

Info

Publication number
JPH0558911A
JPH0558911A JP3215502A JP21550291A JPH0558911A JP H0558911 A JPH0558911 A JP H0558911A JP 3215502 A JP3215502 A JP 3215502A JP 21550291 A JP21550291 A JP 21550291A JP H0558911 A JPH0558911 A JP H0558911A
Authority
JP
Japan
Prior art keywords
expectorant
antitussive
sputum
compound
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3215502A
Other languages
English (en)
Japanese (ja)
Inventor
Nobuo Takeda
信雄 武田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
N D SHINYAKU KAIHATSU KENKYUSHO KK
Original Assignee
N D SHINYAKU KAIHATSU KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N D SHINYAKU KAIHATSU KENKYUSHO KK filed Critical N D SHINYAKU KAIHATSU KENKYUSHO KK
Priority to JP3215502A priority Critical patent/JPH0558911A/ja
Priority to CA002076114A priority patent/CA2076114A1/en
Priority to KR1019920014847A priority patent/KR930003909A/ko
Priority to EP19920114085 priority patent/EP0529484A1/en
Priority to TW081106676A priority patent/TW207948B/zh
Publication of JPH0558911A publication Critical patent/JPH0558911A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP3215502A 1991-08-27 1991-08-27 鎮咳去痰剤 Pending JPH0558911A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP3215502A JPH0558911A (ja) 1991-08-27 1991-08-27 鎮咳去痰剤
CA002076114A CA2076114A1 (en) 1991-08-27 1992-08-13 Antitussive and expectorant composition
KR1019920014847A KR930003909A (ko) 1991-08-27 1992-08-18 진해 거담제
EP19920114085 EP0529484A1 (en) 1991-08-27 1992-08-18 Antitussive and expectorant composition
TW081106676A TW207948B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-08-27 1992-08-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3215502A JPH0558911A (ja) 1991-08-27 1991-08-27 鎮咳去痰剤

Publications (1)

Publication Number Publication Date
JPH0558911A true JPH0558911A (ja) 1993-03-09

Family

ID=16673461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3215502A Pending JPH0558911A (ja) 1991-08-27 1991-08-27 鎮咳去痰剤

Country Status (5)

Country Link
EP (1) EP0529484A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0558911A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR930003909A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2076114A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW207948B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013040214A (ja) * 2000-05-19 2013-02-28 Astrazeneca Ab 新規方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540633A1 (de) * 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013040214A (ja) * 2000-05-19 2013-02-28 Astrazeneca Ab 新規方法
JP2015042693A (ja) * 2000-05-19 2015-03-05 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ 新規方法

Also Published As

Publication number Publication date
TW207948B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-06-21
KR930003909A (ko) 1993-03-22
EP0529484A1 (en) 1993-03-03
CA2076114A1 (en) 1993-02-28

Similar Documents

Publication Publication Date Title
RU2199322C2 (ru) Новое применение будезонида и формотерола
EP0831777B1 (en) Dinucleotides useful for the treatment of lung disease
AU749751B2 (en) Pulmonary and nasal delivery of raloxifene
KR100277622B1 (ko) 흡입용 초미립자 분말 및 그의 제조방법
US20040198708A1 (en) Formulations of mometasone and a bronchodilator for pulmonary administration
KR20110120283A (ko) 흡입용 약학적 조성물
Oh et al. Cocaine induced eosinophilic lung disease.
WO2021230340A1 (ja) 新規吸入剤
Fok et al. Delivery of salbutamol to nonventilated preterm infants by metered-dose inhaler, jet nebulizer, and ultrasonic nebulizer
OA12370A (en) Pharmaceutical formulation of salmeterol and fluticazone propionate.
JPH0558911A (ja) 鎮咳去痰剤
US9539248B2 (en) Agent for ameliorating chronic obstructive pulmonary disease
Avila-Castanon et al. Formoterol vs. Albuterol administered via Turbuhaler® System in the emergency treatment of acute asthma in children
US8686027B1 (en) Method for treating bronchial diseases
JP2002047177A (ja) 気管支作用剤
Fujimura et al. Effect of Ipratropium Bromide on Airway Cough Sensitivity to Inhaled Capsaicin in Patients with Asthma and Sinobronchial Syndrome
CZ20003544A3 (cs) Pulmonární a nasální podávání raloxifenu
AU3892895A (en) Treatment of pulmonary conditions associated with insufficient secretion of surfactant